| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis Imperfecta | 17 | 2024 | 167 | 5.500 |
Why?
|
| Bone and Bones | 13 | 2021 | 294 | 2.440 |
Why?
|
| Osteoblasts | 8 | 2024 | 160 | 2.380 |
Why?
|
| Osteogenesis | 9 | 2024 | 162 | 2.090 |
Why?
|
| Osteoporosis | 5 | 2023 | 132 | 1.570 |
Why?
|
| Genetic Therapy | 6 | 2018 | 683 | 1.390 |
Why?
|
| Proteoglycans | 3 | 2018 | 79 | 1.380 |
Why?
|
| Mutation | 27 | 2024 | 5939 | 1.310 |
Why?
|
| Tacrolimus Binding Proteins | 3 | 2021 | 70 | 1.310 |
Why?
|
| SOX9 Transcription Factor | 2 | 2024 | 86 | 1.300 |
Why?
|
| Osteochondrodysplasias | 5 | 2019 | 66 | 1.280 |
Why?
|
| Cartilage, Articular | 4 | 2020 | 58 | 1.250 |
Why?
|
| Urea Cycle Disorders, Inborn | 6 | 2019 | 84 | 1.220 |
Why?
|
| Chondrogenesis | 5 | 2022 | 27 | 1.220 |
Why?
|
| Wnt1 Protein | 4 | 2018 | 74 | 1.180 |
Why?
|
| MAP Kinase Signaling System | 3 | 2024 | 302 | 1.120 |
Why?
|
| Motor Activity | 2 | 2021 | 504 | 1.120 |
Why?
|
| Osteoarthritis | 4 | 2018 | 97 | 1.100 |
Why?
|
| Osteocytes | 2 | 2017 | 12 | 1.070 |
Why?
|
| Intellectual Disability | 11 | 2024 | 1048 | 1.060 |
Why?
|
| Arginase | 2 | 2018 | 35 | 1.030 |
Why?
|
| Bone Density | 6 | 2017 | 351 | 1.030 |
Why?
|
| Awards and Prizes | 2 | 2018 | 64 | 1.010 |
Why?
|
| Mice | 41 | 2024 | 17594 | 1.000 |
Why?
|
| Animals | 54 | 2025 | 33045 | 0.990 |
Why?
|
| Exome | 15 | 2020 | 1064 | 0.970 |
Why?
|
| Argininosuccinate Lyase | 2 | 2018 | 65 | 0.970 |
Why?
|
| Cell Differentiation | 6 | 2024 | 1842 | 0.960 |
Why?
|
| Fractures, Bone | 3 | 2017 | 190 | 0.940 |
Why?
|
| Platelet-Rich Plasma | 3 | 2021 | 19 | 0.930 |
Why?
|
| Collagen | 6 | 2022 | 290 | 0.920 |
Why?
|
| Rare Diseases | 3 | 2018 | 201 | 0.910 |
Why?
|
| MicroRNAs | 3 | 2018 | 872 | 0.900 |
Why?
|
| Disease Models, Animal | 18 | 2023 | 4426 | 0.890 |
Why?
|
| Interferons | 1 | 2025 | 133 | 0.860 |
Why?
|
| Membrane Proteins | 6 | 2024 | 1569 | 0.850 |
Why?
|
| Chondrocytes | 4 | 2021 | 47 | 0.840 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 2022 | 49 | 0.840 |
Why?
|
| Scleroderma, Systemic | 1 | 2025 | 127 | 0.830 |
Why?
|
| Receptor, Notch1 | 2 | 2014 | 75 | 0.790 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2021 | 152 | 0.790 |
Why?
|
| Phenotype | 18 | 2025 | 4302 | 0.770 |
Why?
|
| Signal Transduction | 10 | 2025 | 4472 | 0.760 |
Why?
|
| Collagen Type II | 4 | 2017 | 23 | 0.760 |
Why?
|
| Hyperalgesia | 2 | 2020 | 24 | 0.750 |
Why?
|
| Cartilage | 4 | 2018 | 50 | 0.750 |
Why?
|
| Leukocytes | 3 | 2021 | 202 | 0.740 |
Why?
|
| Machine Learning | 1 | 2025 | 325 | 0.720 |
Why?
|
| Collagen Type I | 8 | 2022 | 113 | 0.710 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2018 | 53 | 0.710 |
Why?
|
| Bone Diseases | 2 | 2020 | 42 | 0.710 |
Why?
|
| Joints | 1 | 2021 | 25 | 0.700 |
Why?
|
| Achilles Tendon | 1 | 2021 | 10 | 0.700 |
Why?
|
| Patellar Ligament | 1 | 2021 | 11 | 0.700 |
Why?
|
| Mice, Transgenic | 10 | 2024 | 2310 | 0.690 |
Why?
|
| Adenoviridae | 4 | 2018 | 573 | 0.680 |
Why?
|
| Transforming Growth Factor beta | 3 | 2022 | 444 | 0.680 |
Why?
|
| Argininosuccinic Aciduria | 2 | 2018 | 55 | 0.670 |
Why?
|
| Hydroxylation | 4 | 2021 | 48 | 0.660 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2025 | 3262 | 0.620 |
Why?
|
| Hyperammonemia | 3 | 2015 | 60 | 0.600 |
Why?
|
| Humans | 80 | 2025 | 126679 | 0.590 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 286 | 0.580 |
Why?
|
| Nitric Oxide | 2 | 2018 | 461 | 0.580 |
Why?
|
| Osteoarthritis, Knee | 3 | 2021 | 266 | 0.570 |
Why?
|
| Blepharophimosis | 3 | 2020 | 25 | 0.560 |
Why?
|
| Gene Deletion | 2 | 2021 | 767 | 0.560 |
Why?
|
| Cartilage Diseases | 1 | 2018 | 14 | 0.560 |
Why?
|
| Bone Remodeling | 1 | 2018 | 55 | 0.550 |
Why?
|
| Osteoclasts | 3 | 2020 | 64 | 0.540 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 283 | 0.540 |
Why?
|
| Aspirin | 1 | 2019 | 209 | 0.540 |
Why?
|
| Arthritis, Experimental | 2 | 2018 | 20 | 0.540 |
Why?
|
| Bone Neoplasms | 4 | 2020 | 428 | 0.540 |
Why?
|
| Male | 48 | 2025 | 62490 | 0.530 |
Why?
|
| Carrier Proteins | 5 | 2023 | 1011 | 0.520 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2018 | 459 | 0.520 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2014 | 72 | 0.520 |
Why?
|
| Arginine | 2 | 2018 | 335 | 0.510 |
Why?
|
| Mice, Knockout | 13 | 2021 | 3709 | 0.510 |
Why?
|
| Homeostasis | 3 | 2020 | 689 | 0.510 |
Why?
|
| Ammonia | 2 | 2015 | 70 | 0.500 |
Why?
|
| Ubiquitination | 1 | 2017 | 168 | 0.490 |
Why?
|
| Genetics, Medical | 1 | 2017 | 116 | 0.490 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 198 | 0.480 |
Why?
|
| Histone Acetyltransferases | 3 | 2020 | 224 | 0.480 |
Why?
|
| Regeneration | 1 | 2018 | 206 | 0.480 |
Why?
|
| Serpins | 1 | 2015 | 34 | 0.480 |
Why?
|
| Hyperargininemia | 1 | 2015 | 13 | 0.480 |
Why?
|
| Critical Illness | 1 | 2020 | 604 | 0.470 |
Why?
|
| Leadership | 1 | 2018 | 235 | 0.470 |
Why?
|
| Nerve Growth Factors | 1 | 2015 | 69 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 824 | 0.460 |
Why?
|
| Female | 47 | 2025 | 68275 | 0.460 |
Why?
|
| Developmental Disabilities | 5 | 2021 | 718 | 0.450 |
Why?
|
| Endothelial Cells | 1 | 2018 | 501 | 0.450 |
Why?
|
| Pedigree | 10 | 2025 | 1656 | 0.450 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 376 | 0.450 |
Why?
|
| Child, Preschool | 26 | 2021 | 14336 | 0.440 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 287 | 0.430 |
Why?
|
| Glutamine | 1 | 2015 | 196 | 0.430 |
Why?
|
| Osteosarcoma | 2 | 2014 | 259 | 0.430 |
Why?
|
| Eye Proteins | 1 | 2015 | 229 | 0.430 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 14 | 0.430 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 108 | 0.430 |
Why?
|
| Abnormalities, Multiple | 5 | 2018 | 964 | 0.420 |
Why?
|
| Enterocytes | 1 | 2014 | 65 | 0.420 |
Why?
|
| Craniofacial Abnormalities | 2 | 2013 | 252 | 0.420 |
Why?
|
| Codon, Initiator | 1 | 2013 | 8 | 0.410 |
Why?
|
| Urogenital Abnormalities | 2 | 2012 | 160 | 0.400 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 56 | 0.400 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2013 | 12 | 0.400 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2304 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 4502 | 0.380 |
Why?
|
| Stem Cells | 4 | 2024 | 683 | 0.380 |
Why?
|
| Child | 28 | 2025 | 25081 | 0.380 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 29 | 0.380 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2012 | 11 | 0.380 |
Why?
|
| Blepharoptosis | 2 | 2012 | 67 | 0.380 |
Why?
|
| Receptor, Notch2 | 1 | 2012 | 12 | 0.380 |
Why?
|
| Genotype | 5 | 2019 | 2593 | 0.370 |
Why?
|
| Animals, Newborn | 5 | 2021 | 1015 | 0.370 |
Why?
|
| Point Mutation | 1 | 2013 | 334 | 0.370 |
Why?
|
| Noonan Syndrome | 1 | 2012 | 31 | 0.370 |
Why?
|
| Cell Line | 5 | 2018 | 2560 | 0.360 |
Why?
|
| Knee Joint | 1 | 2013 | 163 | 0.360 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 416 | 0.360 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 186 | 0.350 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2014 | 249 | 0.340 |
Why?
|
| Tendons | 3 | 2021 | 28 | 0.340 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 899 | 0.340 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 327 | 0.340 |
Why?
|
| Phenylbutyrates | 3 | 2015 | 55 | 0.330 |
Why?
|
| Molecular Chaperones | 4 | 2022 | 169 | 0.330 |
Why?
|
| Marfan Syndrome | 1 | 2012 | 144 | 0.330 |
Why?
|
| Haploinsufficiency | 4 | 2022 | 265 | 0.330 |
Why?
|
| X-Ray Microtomography | 5 | 2020 | 96 | 0.320 |
Why?
|
| Genetic Association Studies | 5 | 2019 | 808 | 0.320 |
Why?
|
| Hypertension | 1 | 2018 | 1301 | 0.320 |
Why?
|
| Radiography | 5 | 2016 | 752 | 0.310 |
Why?
|
| Proteins | 2 | 2014 | 1018 | 0.300 |
Why?
|
| Microcephaly | 3 | 2025 | 343 | 0.300 |
Why?
|
| NF-kappa B | 3 | 2021 | 438 | 0.300 |
Why?
|
| Lysine | 2 | 2021 | 173 | 0.290 |
Why?
|
| Neurons | 1 | 2018 | 1919 | 0.290 |
Why?
|
| Genetic Variation | 3 | 2020 | 1508 | 0.280 |
Why?
|
| Mice, 129 Strain | 2 | 2021 | 97 | 0.280 |
Why?
|
| Liver | 1 | 2015 | 1763 | 0.280 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2023 | 415 | 0.280 |
Why?
|
| Musculoskeletal Abnormalities | 3 | 2019 | 63 | 0.270 |
Why?
|
| Quantitative Trait Loci | 2 | 2025 | 290 | 0.260 |
Why?
|
| Calcification, Physiologic | 2 | 2017 | 24 | 0.260 |
Why?
|
| Genetic Testing | 3 | 2020 | 1056 | 0.260 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2017 | 167 | 0.250 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2017 | 348 | 0.250 |
Why?
|
| Gene Transfer Techniques | 3 | 2018 | 336 | 0.250 |
Why?
|
| Receptors, Notch | 3 | 2020 | 195 | 0.250 |
Why?
|
| Heterozygote | 6 | 2021 | 690 | 0.250 |
Why?
|
| Base Sequence | 4 | 2015 | 2756 | 0.250 |
Why?
|
| History, 21st Century | 2 | 2018 | 264 | 0.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2024 | 576 | 0.240 |
Why?
|
| Procollagen-Proline Dioxygenase | 2 | 2017 | 31 | 0.240 |
Why?
|
| Adolescent | 16 | 2021 | 19987 | 0.240 |
Why?
|
| History, 20th Century | 2 | 2018 | 369 | 0.240 |
Why?
|
| Amino Acids | 2 | 2018 | 615 | 0.240 |
Why?
|
| Frameshift Mutation | 2 | 2025 | 190 | 0.240 |
Why?
|
| Sequence Analysis, DNA | 6 | 2018 | 1707 | 0.230 |
Why?
|
| Glycerol | 2 | 2015 | 80 | 0.230 |
Why?
|
| Jagged-1 Protein | 2 | 2017 | 51 | 0.230 |
Why?
|
| Infant | 13 | 2021 | 12760 | 0.230 |
Why?
|
| Liver Transplantation | 2 | 2014 | 1102 | 0.230 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2893 | 0.230 |
Why?
|
| Seizures | 3 | 2021 | 847 | 0.220 |
Why?
|
| Nutritional Status | 1 | 2006 | 299 | 0.220 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2025 | 78 | 0.220 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 3584 | 0.210 |
Why?
|
| Limb Deformities, Congenital | 2 | 2016 | 109 | 0.210 |
Why?
|
| Cohort Studies | 4 | 2020 | 4953 | 0.210 |
Why?
|
| HEK293 Cells | 2 | 2017 | 767 | 0.210 |
Why?
|
| Cataract | 2 | 2015 | 142 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 718 | 0.210 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 136 | 0.210 |
Why?
|
| Homozygote | 2 | 2017 | 540 | 0.210 |
Why?
|
| Genome-Wide Association Study | 2 | 2025 | 1728 | 0.200 |
Why?
|
| Ligaments | 2 | 2021 | 21 | 0.200 |
Why?
|
| Young Adult | 10 | 2021 | 9655 | 0.200 |
Why?
|
| Adult | 16 | 2024 | 30379 | 0.190 |
Why?
|
| Bone Diseases, Developmental | 4 | 2017 | 60 | 0.190 |
Why?
|
| Glycolysis | 1 | 2023 | 167 | 0.190 |
Why?
|
| Mutation, Missense | 3 | 2018 | 891 | 0.190 |
Why?
|
| Gene Expression | 3 | 2017 | 1482 | 0.190 |
Why?
|
| Heart Defects, Congenital | 3 | 2018 | 1847 | 0.190 |
Why?
|
| Extracellular Matrix | 2 | 2021 | 223 | 0.190 |
Why?
|
| Collagen Type V | 1 | 2022 | 3 | 0.190 |
Why?
|
| Genes, Recessive | 2 | 2021 | 184 | 0.190 |
Why?
|
| Sequence Deletion | 2 | 2015 | 510 | 0.180 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 14 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2025 | 3311 | 0.180 |
Why?
|
| Coatomer Protein | 1 | 2021 | 30 | 0.180 |
Why?
|
| Fibrillar Collagens | 1 | 2021 | 14 | 0.180 |
Why?
|
| Zebrafish | 3 | 2021 | 402 | 0.180 |
Why?
|
| Phosphorylation | 3 | 2021 | 1536 | 0.180 |
Why?
|
| Drosophila Proteins | 2 | 2025 | 757 | 0.180 |
Why?
|
| Malformations of Cortical Development | 2 | 2018 | 53 | 0.180 |
Why?
|
| Hand Strength | 1 | 2021 | 56 | 0.170 |
Why?
|
| Physical Endurance | 1 | 2021 | 42 | 0.170 |
Why?
|
| Genetic Vectors | 2 | 2018 | 890 | 0.170 |
Why?
|
| Ossification, Heterotopic | 1 | 2021 | 37 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 533 | 0.170 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2021 | 86 | 0.170 |
Why?
|
| Fasting | 2 | 2015 | 300 | 0.160 |
Why?
|
| Spectrin | 1 | 2021 | 70 | 0.160 |
Why?
|
| Micrognathism | 3 | 2018 | 65 | 0.160 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 197 | 0.160 |
Why?
|
| Cross-Linking Reagents | 2 | 2017 | 50 | 0.160 |
Why?
|
| Hand Deformities, Congenital | 3 | 2018 | 95 | 0.160 |
Why?
|
| Growth Disorders | 3 | 2016 | 183 | 0.160 |
Why?
|
| Gait | 1 | 2021 | 142 | 0.160 |
Why?
|
| Diphosphonates | 1 | 2020 | 41 | 0.160 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 35 | 0.160 |
Why?
|
| Nitrogen | 1 | 2020 | 122 | 0.160 |
Why?
|
| Infant, Newborn | 6 | 2021 | 8343 | 0.160 |
Why?
|
| Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2019 | 3 | 0.160 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2019 | 18 | 0.160 |
Why?
|
| Amino Acid Sequence | 4 | 2017 | 2541 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 60 | 0.150 |
Why?
|
| Fibrosis | 1 | 2021 | 400 | 0.150 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2019 | 26 | 0.150 |
Why?
|
| Actins | 1 | 2021 | 311 | 0.150 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2019 | 48 | 0.150 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 42 | 0.150 |
Why?
|
| Thrombin | 1 | 2019 | 55 | 0.150 |
Why?
|
| Stifle | 1 | 2018 | 1 | 0.150 |
Why?
|
| Pigmentation Disorders | 1 | 2018 | 22 | 0.150 |
Why?
|
| Platelet Activation | 1 | 2019 | 66 | 0.150 |
Why?
|
| Osteophyte | 1 | 2018 | 7 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 58 | 0.150 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 119 | 0.150 |
Why?
|
| Thy-1 Antigens | 1 | 2018 | 20 | 0.140 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 13 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2018 | 28 | 0.140 |
Why?
|
| Synovitis | 1 | 2018 | 24 | 0.140 |
Why?
|
| Megalencephaly | 1 | 2018 | 59 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2025 | 2746 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2024 | 526 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 134 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 416 | 0.140 |
Why?
|
| Adipocytes | 1 | 2019 | 167 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 89 | 0.140 |
Why?
|
| Delphi Technique | 1 | 2019 | 240 | 0.140 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2017 | 12 | 0.140 |
Why?
|
| Biomarkers | 2 | 2019 | 3219 | 0.140 |
Why?
|
| Hearing Loss | 1 | 2019 | 199 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2018 | 188 | 0.130 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 119 | 0.130 |
Why?
|
| Fibronectins | 1 | 2017 | 99 | 0.130 |
Why?
|
| Peptides | 1 | 2021 | 828 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2021 | 363 | 0.130 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 1859 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 235 | 0.130 |
Why?
|
| Mobius Syndrome | 1 | 2017 | 7 | 0.130 |
Why?
|
| Crystallization | 1 | 2017 | 81 | 0.130 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2017 | 21 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 233 | 0.130 |
Why?
|
| Family | 2 | 2013 | 575 | 0.130 |
Why?
|
| Tubulin | 1 | 2017 | 67 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 330 | 0.130 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 88 | 0.130 |
Why?
|
| RNA Interference | 2 | 2019 | 492 | 0.130 |
Why?
|
| Middle Aged | 8 | 2025 | 27672 | 0.130 |
Why?
|
| Protein Stability | 1 | 2017 | 162 | 0.130 |
Why?
|
| Hip Joint | 1 | 2016 | 50 | 0.130 |
Why?
|
| Bone Development | 2 | 2014 | 54 | 0.130 |
Why?
|
| Autoantigens | 1 | 2017 | 104 | 0.120 |
Why?
|
| Iliac Artery | 1 | 2016 | 64 | 0.120 |
Why?
|
| Fibroblasts | 4 | 2025 | 819 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2019 | 312 | 0.120 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 319 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 122 | 0.120 |
Why?
|
| Models, Biological | 1 | 2021 | 1370 | 0.120 |
Why?
|
| Multigene Family | 1 | 2017 | 288 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 191 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 253 | 0.120 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 98 | 0.120 |
Why?
|
| 1-Carboxyglutamic Acid | 1 | 2015 | 2 | 0.120 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 269 | 0.120 |
Why?
|
| Organ Size | 1 | 2017 | 429 | 0.120 |
Why?
|
| Antibodies | 1 | 2017 | 351 | 0.120 |
Why?
|
| Tibial Fractures | 1 | 2016 | 64 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2017 | 404 | 0.120 |
Why?
|
| DNA Damage | 1 | 2019 | 498 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 579 | 0.120 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 92 | 0.120 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 459 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 81 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2015 | 11 | 0.120 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2015 | 15 | 0.120 |
Why?
|
| Steroid Isomerases | 1 | 2015 | 8 | 0.120 |
Why?
|
| Myosins | 1 | 2015 | 41 | 0.120 |
Why?
|
| Metabolomics | 1 | 2019 | 455 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2017 | 333 | 0.110 |
Why?
|
| Alleles | 4 | 2024 | 1609 | 0.110 |
Why?
|
| Arthrogryposis | 1 | 2015 | 36 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 60 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 83 | 0.110 |
Why?
|
| Alopecia | 1 | 2015 | 40 | 0.110 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2014 | 5 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 2788 | 0.110 |
Why?
|
| Hypophosphatemia | 1 | 2014 | 9 | 0.110 |
Why?
|
| Age of Onset | 2 | 2013 | 609 | 0.110 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2014 | 13 | 0.110 |
Why?
|
| Nephrocalcinosis | 1 | 2014 | 9 | 0.110 |
Why?
|
| Deafness | 1 | 2015 | 81 | 0.110 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2014 | 9 | 0.110 |
Why?
|
| Connective Tissue | 1 | 2014 | 27 | 0.110 |
Why?
|
| Dwarfism | 1 | 2015 | 102 | 0.110 |
Why?
|
| Skeleton | 1 | 2014 | 4 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 350 | 0.110 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 45 | 0.110 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 61 | 0.110 |
Why?
|
| Cyclophilins | 1 | 2014 | 19 | 0.110 |
Why?
|
| Myopia | 1 | 2015 | 106 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2017 | 742 | 0.110 |
Why?
|
| Nails, Malformed | 1 | 2013 | 7 | 0.110 |
Why?
|
| Thiophenes | 1 | 2014 | 68 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 686 | 0.100 |
Why?
|
| Inflammation | 1 | 2021 | 1420 | 0.100 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 361 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 273 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 756 | 0.100 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 52 | 0.100 |
Why?
|
| Forearm | 1 | 2013 | 38 | 0.100 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2013 | 35 | 0.100 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 91 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2013 | 6 | 0.100 |
Why?
|
| Epilepsy | 1 | 2021 | 844 | 0.100 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 119 | 0.100 |
Why?
|
| Proteolysis | 1 | 2014 | 177 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 67 | 0.100 |
Why?
|
| Brachydactyly | 1 | 2013 | 10 | 0.100 |
Why?
|
| Myofibromatosis | 1 | 2013 | 10 | 0.100 |
Why?
|
| Laser Capture Microdissection | 1 | 2013 | 8 | 0.100 |
Why?
|
| Infant Formula | 1 | 2014 | 104 | 0.100 |
Why?
|
| Flavoproteins | 1 | 2013 | 20 | 0.100 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2013 | 11 | 0.100 |
Why?
|
| Toes | 1 | 2013 | 27 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 83 | 0.100 |
Why?
|
| Protein Folding | 1 | 2014 | 214 | 0.100 |
Why?
|
| Internationality | 1 | 2013 | 128 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2014 | 708 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 222 | 0.100 |
Why?
|
| Hepatocytes | 1 | 2014 | 231 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2018 | 1312 | 0.100 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2012 | 6 | 0.100 |
Why?
|
| Ectodermal Dysplasia | 1 | 2013 | 47 | 0.100 |
Why?
|
| Fibrillins | 1 | 2012 | 28 | 0.100 |
Why?
|
| Osteopetrosis | 1 | 2012 | 12 | 0.100 |
Why?
|
| Osteosclerosis | 1 | 2012 | 11 | 0.100 |
Why?
|
| Physicians | 1 | 2019 | 620 | 0.100 |
Why?
|
| Exosomes | 1 | 2013 | 58 | 0.100 |
Why?
|
| Hand | 1 | 2013 | 95 | 0.090 |
Why?
|
| Fibrillin-1 | 1 | 2012 | 59 | 0.090 |
Why?
|
| Patella | 1 | 2012 | 27 | 0.090 |
Why?
|
| Scrotum | 1 | 2012 | 29 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2014 | 406 | 0.090 |
Why?
|
| Transfection | 1 | 2014 | 946 | 0.090 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2012 | 36 | 0.090 |
Why?
|
| Dependovirus | 1 | 2013 | 144 | 0.090 |
Why?
|
| Self Report | 1 | 2015 | 534 | 0.090 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 72 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1293 | 0.090 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 155 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2021 | 6203 | 0.090 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 193 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 87 | 0.090 |
Why?
|
| Adipokines | 1 | 2012 | 116 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 988 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2013 | 318 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 272 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 344 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 563 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1424 | 0.090 |
Why?
|
| Genome, Human | 1 | 2018 | 1279 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 785 | 0.090 |
Why?
|
| Mass Spectrometry | 3 | 2019 | 348 | 0.090 |
Why?
|
| Rats | 2 | 2014 | 3387 | 0.090 |
Why?
|
| Injections, Intra-Articular | 2 | 2021 | 32 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1758 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 637 | 0.080 |
Why?
|
| Hemophilia A | 1 | 2011 | 24 | 0.080 |
Why?
|
| Factor VIII | 1 | 2011 | 47 | 0.080 |
Why?
|
| Cell Movement | 1 | 2014 | 849 | 0.080 |
Why?
|
| Quality of Life | 2 | 2021 | 2027 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2225 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1204 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 2337 | 0.080 |
Why?
|
| Syndrome | 3 | 2018 | 1135 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2009 | 93 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 576 | 0.070 |
Why?
|
| Exons | 2 | 2022 | 757 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 2 | 2021 | 202 | 0.070 |
Why?
|
| Brain | 2 | 2021 | 3037 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 658 | 0.070 |
Why?
|
| Transcriptome | 1 | 2014 | 1051 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2022 | 96 | 0.070 |
Why?
|
| Apoptosis | 1 | 2014 | 1811 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 971 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 622 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3497 | 0.070 |
Why?
|
| Drosophila | 2 | 2024 | 767 | 0.060 |
Why?
|
| Deficiency Diseases | 1 | 2006 | 9 | 0.060 |
Why?
|
| DNA | 1 | 2012 | 1419 | 0.060 |
Why?
|
| Neck | 2 | 2018 | 141 | 0.060 |
Why?
|
| Disease Progression | 3 | 2020 | 2109 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 398 | 0.060 |
Why?
|
| Face | 2 | 2018 | 193 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2021 | 1398 | 0.060 |
Why?
|
| Chromosome Deletion | 1 | 2009 | 642 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1283 | 0.060 |
Why?
|
| Diet, Protein-Restricted | 1 | 2006 | 80 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 683 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 2 | 2016 | 85 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 968 | 0.050 |
Why?
|
| Time Factors | 1 | 2014 | 6126 | 0.050 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 230 | 0.050 |
Why?
|
| Allosteric Regulation | 2 | 2014 | 60 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2024 | 76 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2023 | 92 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 1351 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2022 | 10 | 0.050 |
Why?
|
| TCF Transcription Factors | 1 | 2022 | 14 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 325 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2013 | 241 | 0.050 |
Why?
|
| Neural Crest | 1 | 2022 | 52 | 0.050 |
Why?
|
| Butylamines | 1 | 2022 | 1 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 228 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 73 | 0.050 |
Why?
|
| Cornea | 2 | 2017 | 494 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2023 | 646 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 70 | 0.040 |
Why?
|
| beta Catenin | 1 | 2022 | 205 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 90 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 137 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2022 | 188 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 578 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 5113 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2021 | 39 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12537 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 101 | 0.040 |
Why?
|
| Alendronate | 1 | 2020 | 21 | 0.040 |
Why?
|
| Menisci, Tibial | 1 | 2020 | 37 | 0.040 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 17 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 151 | 0.040 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2020 | 31 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2021 | 176 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2013 | 1057 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 562 | 0.040 |
Why?
|
| PAX3 Transcription Factor | 1 | 2019 | 29 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2025 | 808 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 1098 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 202 | 0.040 |
Why?
|
| North America | 1 | 2019 | 248 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 57 | 0.040 |
Why?
|
| Methylation | 1 | 2019 | 196 | 0.040 |
Why?
|
| Carpal Joints | 1 | 2018 | 1 | 0.040 |
Why?
|
| Forelimb | 1 | 2018 | 12 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2018 | 26 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2018 | 17 | 0.040 |
Why?
|
| Ligaments, Articular | 1 | 2018 | 21 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2019 | 79 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 160 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2018 | 97 | 0.040 |
Why?
|
| Horses | 1 | 2018 | 103 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 132 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 334 | 0.030 |
Why?
|
| Urea | 1 | 2019 | 224 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 279 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 191 | 0.030 |
Why?
|
| Chromosome Duplication | 1 | 2018 | 147 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2019 | 183 | 0.030 |
Why?
|
| White Matter | 1 | 2020 | 205 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2021 | 422 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2019 | 207 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 3901 | 0.030 |
Why?
|
| Dentin | 1 | 2017 | 2 | 0.030 |
Why?
|
| Mosaicism | 1 | 2018 | 230 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2017 | 34 | 0.030 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2017 | 27 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 29 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 968 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 303 | 0.030 |
Why?
|
| Eczema | 1 | 2016 | 32 | 0.030 |
Why?
|
| Ocular Motility Disorders | 1 | 2017 | 35 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 2017 | 50 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 452 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 63 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 821 | 0.030 |
Why?
|
| Hindlimb | 1 | 2016 | 73 | 0.030 |
Why?
|
| Facies | 1 | 2016 | 156 | 0.030 |
Why?
|
| Orbital Diseases | 1 | 2017 | 62 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 116 | 0.030 |
Why?
|
| Scoliosis | 1 | 2017 | 140 | 0.030 |
Why?
|
| Aged | 4 | 2015 | 20321 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 502 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 533 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 517 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2015 | 19 | 0.030 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2015 | 24 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2013 | 16985 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 392 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2015 | 60 | 0.030 |
Why?
|
| Sclera | 1 | 2015 | 35 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 946 | 0.030 |
Why?
|
| Hypercalciuria | 1 | 2014 | 8 | 0.030 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 22 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2014 | 56 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 2014 | 42 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 52 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 77 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 75 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 396 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 260 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 516 | 0.030 |
Why?
|
| ADAMTS7 Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 291 | 0.030 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2013 | 16 | 0.030 |
Why?
|
| Phenylpropionates | 1 | 2013 | 2 | 0.030 |
Why?
|
| Isoleucine | 1 | 2013 | 25 | 0.030 |
Why?
|
| Receptor, Notch3 | 1 | 2013 | 11 | 0.030 |
Why?
|
| Aorta | 1 | 2017 | 518 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2013 | 25 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2969 | 0.020 |
Why?
|
| Research Subjects | 1 | 2013 | 50 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 152 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 110 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2015 | 200 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 306 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 781 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 950 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 356 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3656 | 0.020 |
Why?
|
| Consanguinity | 1 | 2012 | 118 | 0.020 |
Why?
|
| Leucine | 1 | 2013 | 258 | 0.020 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2012 | 16 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 443 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 523 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 824 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 585 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2011 | 38 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 1877 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 352 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 276 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1753 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1595 | 0.020 |
Why?
|
| Epigenomics | 1 | 2012 | 173 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 1185 | 0.020 |
Why?
|
| Osteopoikilosis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1661 | 0.020 |
Why?
|
| Karyotyping | 1 | 2009 | 312 | 0.020 |
Why?
|
| Pediatrics | 1 | 2018 | 1198 | 0.020 |
Why?
|
| Cerebellum | 1 | 2012 | 414 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7370 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2537 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6663 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 560 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3693 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 1191 | 0.020 |
Why?
|
| United States | 1 | 2018 | 11297 | 0.010 |
Why?
|